These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 31245302)

  • 1. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
    Peyclit L; Baron SA; Rolain JM
    Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
    Domalaon R; Okunnu O; Zhanel GG; Schweizer F
    J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
    Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin: new lessons on an old antibiotic.
    Yahav D; Farbman L; Leibovici L; Paul M
    Clin Microbiol Infect; 2012 Jan; 18(1):18-29. PubMed ID: 22168320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates.
    Okdah L; Le Page S; Olaitan AO; Dubourg G; Hadjadj L; Rolain JM
    Int J Antimicrob Agents; 2018 May; 51(5):775-783. PubMed ID: 29421171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
    Kempf M; Rolain JM
    Int J Antimicrob Agents; 2012 Feb; 39(2):105-14. PubMed ID: 22113193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant
    Cheng YS; Sun W; Xu M; Shen M; Khraiwesh M; Sciotti RJ; Zheng W
    Front Cell Infect Microbiol; 2018; 8():438. PubMed ID: 30662875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I; Zer Y; Bosnak VK; Mete AO; Namiduru M
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
    Mediavilla JR; Patrawalla A; Chen L; Chavda KD; Mathema B; Vinnard C; Dever LL; Kreiswirth BN
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the Role of Novel β-Lactam Agents That Target Carbapenem-Resistant Gram-Negative Organisms.
    Tamma PD; Hsu AJ
    J Pediatric Infect Dis Soc; 2019 Jul; 8(3):251-260. PubMed ID: 30793757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y; Telli M; Altunçekiç Yıldırım A; Çalgın MK
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
    Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
    ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colistin, mechanisms and prevalence of resistance.
    Bialvaei AZ; Samadi Kafil H
    Curr Med Res Opin; 2015 Apr; 31(4):707-21. PubMed ID: 25697677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.
    Lora-Tamayo J; Murillo O; Bergen PJ; Nation RL; Poudyal A; Luo X; Yu HY; Ariza J; Li J
    J Antimicrob Chemother; 2014 Sep; 69(9):2434-42. PubMed ID: 24833752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem- and Colistin-Resistant Enterobacter cloacae from Delta, Colorado, in 2015.
    Norgan AP; Freese JM; Tuin PM; Cunningham SA; Jeraldo PR; Patel R
    Antimicrob Agents Chemother; 2016 May; 60(5):3141-4. PubMed ID: 26883705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A broad-spectrum antibiotic adjuvant reverses multidrug-resistant Gram-negative pathogens.
    Song M; Liu Y; Huang X; Ding S; Wang Y; Shen J; Zhu K
    Nat Microbiol; 2020 Aug; 5(8):1040-1050. PubMed ID: 32424338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.